In the current U.S. market environment, investors are navigating mixed signals as they await news on tariffs and digest fresh economic data, with major indices reflecting a cautious sentiment amid broader economic concerns. In such times, companies that showcase high insider ownership coupled with strong earnings growth can be particularly appealing, as insider stakes often indicate confidence in the company's future prospects.
Name | Insider Ownership | Earnings Growth |
Atour Lifestyle Holdings (NasdaqGS:ATAT) | 26% | 25.6% |
Super Micro Computer (NasdaqGS:SMCI) | 14.2% | 29.1% |
Duolingo (NasdaqGS:DUOL) | 14.4% | 36.5% |
Corcept Therapeutics (NasdaqCM:CORT) | 11.7% | 36.7% |
Hims & Hers Health (NYSE:HIMS) | 13.2% | 21.8% |
Astrana Health (NasdaqCM:ASTH) | 13.2% | 29.5% |
Kingstone Companies (NasdaqCM:KINS) | 17.7% | 24.2% |
Astera Labs (NasdaqGS:ALAB) | 15.9% | 61.1% |
BBB Foods (NYSE:TBBB) | 16.5% | 41.1% |
Upstart Holdings (NasdaqGS:UPST) | 12.7% | 100.1% |
Click here to see the full list of 202 stocks from our Fast Growing US Companies With High Insider Ownership screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: OPAL Fuels Inc. focuses on producing and distributing renewable natural gas for heavy and medium-duty trucking fleets, with a market cap of $416.52 million.
Operations: The company's revenue segments include RNG Fuel at $193.37 million, Renewable Power at $46.38 million, and Fuel Station Services at $187.59 million.
Insider Ownership: 11.1%
Earnings Growth Forecast: 29.2% p.a.
OPAL Fuels is experiencing strategic growth, highlighted by joint ventures to develop landfill RNG projects and the acquisition of a fueling station in California. The company expects earnings growth of 29.24% annually, surpassing the US market average. However, profit margins have decreased from 8.7% to 1.6%, and interest payments are not well covered by earnings. Recent executive changes bring experienced leadership with Mr. Kazi Hasan as CFO, potentially enhancing financial strategy and execution capabilities.
Simply Wall St Growth Rating: ★★★★★☆
Overview: ARS Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for severe allergic reactions, with a market cap of approximately $989.35 million.
Operations: The company's revenue is solely derived from its pharmaceuticals segment, amounting to $2.57 million.
Insider Ownership: 19.1%
Earnings Growth Forecast: 61.4% p.a.
ARS Pharmaceuticals is advancing with neffy, an FDA-approved epinephrine nasal spray, now included in major formularies like Cigna and OptumRx. The company expects rapid revenue growth at 47.1% annually, outpacing the US market. Despite trading well below its estimated fair value, ARS forecasts profitability within three years. Recent strategic moves include a $200 million equity offering and international licensing agreements, enhancing its global footprint while maintaining substantial insider ownership to align interests with shareholders.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: UP Fintech Holding Limited offers online brokerage services primarily targeting Chinese investors and has a market cap of approximately $1.29 billion.
Operations: The company generates revenue of $277.35 million from its brokerage services.
Insider Ownership: 19.3%
Earnings Growth Forecast: 25.1% p.a.
UP Fintech Holding is poised for significant growth, with earnings projected to increase 25.1% annually, surpassing the US market's average. Revenue is also expected to grow at 18.4% per year, outpacing broader market trends. Despite a highly volatile share price recently and a forecasted low return on equity of 11.8%, substantial insider ownership aligns management interests with shareholders, potentially mitigating risks associated with its rapid expansion strategy in the competitive fintech sector.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include NasdaqCM:OPAL NasdaqGM:SPRY and NasdaqGS:TIGR.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.